advertisement

Topcon

Shukla AG 11

Showing records 1 to 11 | Display all abstracts from Shukla AG

90159 Outcomes of Valved and Nonvalved Tube Shunts in Neovascular Glaucoma
Shalaby WS
Ophthalmology. Glaucoma 2021; 4: 182-192
89937 Balancing treatments for patients with systemic hypertension and glaucoma
Shukla AG
Expert Opinion in Pharmacotherapy 2020; 21: 2225-2230
90104 Management of Anticoagulation and Antiplatelet Therapy in Glaucoma Surgery
Shukla AG
Journal of Glaucoma 2020; 29: 732-741
89937 Balancing treatments for patients with systemic hypertension and glaucoma
Shukla AG
Expert Opinion in Pharmacotherapy 2020; 21: 2225-2230
90159 Outcomes of Valved and Nonvalved Tube Shunts in Neovascular Glaucoma
Shalaby WS
Ophthalmology. Glaucoma 2021; 4: 182-192
90104 Management of Anticoagulation and Antiplatelet Therapy in Glaucoma Surgery
Shukla AG
Journal of Glaucoma 2020; 29: 732-741
90159 Outcomes of Valved and Nonvalved Tube Shunts in Neovascular Glaucoma
Shalaby WS; Myers JS
Ophthalmology. Glaucoma 2021; 4: 182-192
89937 Balancing treatments for patients with systemic hypertension and glaucoma
Razeghinejad R
Expert Opinion in Pharmacotherapy 2020; 21: 2225-2230
90104 Management of Anticoagulation and Antiplatelet Therapy in Glaucoma Surgery
Ramulu PY
Journal of Glaucoma 2020; 29: 732-741
89937 Balancing treatments for patients with systemic hypertension and glaucoma
Myers JS
Expert Opinion in Pharmacotherapy 2020; 21: 2225-2230
90159 Outcomes of Valved and Nonvalved Tube Shunts in Neovascular Glaucoma
Razeghinejad R; Katz LJ; Pro M; Dale E; Fudemberg SJ; Mantravadi AV; Shukla AG; Shukla AG
Ophthalmology. Glaucoma 2021; 4: 182-192

Issue 21-3

Change Issue


advertisement

Topcon